DHR vs UNH: Which Is the Better Buy?
Side-by-side comparison of Danaher Corporation and UnitedHealth Group Incorporated — fair value, conviction, valuation metrics, and QuantHub research signals.
Updated 2026-06-20.
Danaher Corporation · Healthcare
$177.17
+8.9% upside to fair value
Grade B
High Quality
VS
UnitedHealth Group Incorporated · Healthcare
$400.96
+45.0% upside to fair value
Grade B
High Quality
QuantHub Verdict
UNH has more upside to fair value
(+45.0%).
UNH trades at a lower forward P/E
(30.2x).
These are model outputs — not personalized investment advice.
See all research →
Valuation & Fundamentals
| Metric |
DHR |
UNH |
| Current Price |
$177.17 |
$400.96 |
| Fair Value Estimate |
$192.90 |
$581.39 |
| Upside to Fair Value |
+8.9%
|
+45.0%
|
| Market Cap |
$125.4B |
$364.1B |
| Forward P/E |
34.1x
|
30.2x
|
| EV / EBITDA |
20.8x
|
18.0x
|
| Price / Sales |
5.1x
|
0.8x
|
| Price / FCF |
23.7x
|
18.5x
|
| Revenue Growth YoY |
+3.7%
|
+2.0%
|
| Gross Margin |
60.7%
|
18.8%
|
| Operating Margin |
21.0%
|
4.2%
|
| Return on Equity |
7.1%
|
12.4%
|
| Dividend Yield |
0% |
0% |
| FCF Yield |
4.22%
|
5.4%
|
| Analyst Consensus |
Strong Buy
|
Strong Buy
|
Investment Thesis
Danaher Corporation operates in the healthcare sector, specializing in medical diagnostics and research tools through three balanced platforms: Biotechnology, Life Sciences, and Diagnostics. The company benefits from a durable competitive moat supported by the Danaher Business System, disciplined capital allocation, and a platform-centric organizational structure. Despite modest revenue growth of…
UnitedHealth Group Incorporated operates as a diversified healthcare company with leading positions in healthcare plans through UnitedHealthcare and health services via Optum. The business quality is high due to its durable competitive advantages including scale, integration of Optum and UnitedHealthcare, strong data and distribution infrastructure, and incumbency in Medicare Advantage and care d…
Accumulation Zones
| Metric |
DHR |
UNH |
| Zone Low |
$144.68 |
$436.04 |
| Zone High |
$163.97 |
$494.18 |
| In Buy Zone? |
No
|
Yes
|